5d
11h
Multimorbidity of overweight and obesity alongside anxiety and depressive disorders in individuals with spinal cord injury - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/30183556/
This work is among the first to find evidence that individuals with SCI are at heightened odds of overweight/obesity alongside anxiety and/or depressive disorders. This early work holds clinical implications...
Adults with spinal cord injury had significantly higher odds of anxiety, depression, and overweight/obesity, with elevated multimorbidity risk. Overweight/obese individuals with SCI showed greater likelihood of coexisting anxiety and depressive disorders.
1w
Fighting the epidemic of pediatric metabolic dysfunction-associated steatotic liver disease: Role of non-invasive diagnostics and early pharmacological intervention - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41640966/
The global rise in childhood obesity has made metabolic dysfunction-associated steatotic liver disease (MASLD) the leading cause of pediatric liver disease. Studies have consistently reported alarmingly high rates of advanced...
Mini-review addresses rising pediatric MASLD, emphasizing non-invasive diagnostics for early fibrosis detection and advocating early pharmacological intervention, including GLP-1 receptor agonists, to prevent progression and improve long-term outcomes in children.
1w
Did you know? Hormonal imbalances can subtly influence lipid metabolism, insulin sensitivity, body weight, and renal function. Disruptions in calcium, vitamin D, and magnesium signaling may amplify cardiometabolic risk, underscoring the need for integrated endocrine monitoring across obesity, diabetes, and lipid disorders to support long-term metabolic health.
Could a more holistic approach to hormonal monitoring improve cardiometabolic outcomes across diverse metabolic conditions?
Could a more holistic approach to hormonal monitoring improve cardiometabolic outcomes across diverse metabolic conditions?
1w
Emerging evidence links hormonal imbalance to metabolic dysfunction, oxidative stress, and elevated cardiovascular risk. Conditions marked by insulin resistance, dyslipidemia, and obesity share disrupted endocrine signaling that accelerates cardiometabolic complications across populations.